Literature DB >> 8498409

Complications of fetal blood sampling.

A Ghidini1, W Sepulveda, C J Lockwood, R Romero.   

Abstract

To examine the incidence and significance of complications related to percutaneous fetal blood sampling, we reviewed all the articles published in the English literature on this procedure. Risks of complications and adverse outcomes depend mainly on the gestational age at the time of the procedure, the operator's experience, and the indication for the procedure. To determine the incidence of fetal losses, we pooled the data from series with > 100 cases. After exclusion of cases where some fetal pathologic condition was present, we determined the incidence of adverse outcomes in a low-risk population. In this population fetal blood sampling performed by an experienced operator carries about a 1.4% risk of fetal loss before 28 weeks' gestation and a 1.4% risk of perinatal death (after 28 weeks).

Entities:  

Mesh:

Year:  1993        PMID: 8498409     DOI: 10.1016/s0002-9378(11)90761-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Fetal brain disruption sequence in a newborn infant with a history of cordocentesis at 21 weeks gestation.

Authors:  N Villó; J Beceiro; M Cebrero; E G de Frias
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

Review 2.  Treatment of Fetal Supraventricular Tachycardia.

Authors:  Bridget B Zoeller
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

3.  Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases.

Authors:  A Davoren; P McParland; C A Barnes; W G Murphy
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Fetal blood sampling in retreat.

Authors:  N M Fisk; S Bower
Journal:  BMJ       Date:  1993-07-17

5.  Prenatal diagnosis of congenital cytomegalovirus infection.

Authors:  T Lazzarotto; B Guerra; P Spezzacatena; S Varani; L Gabrielli; P Pradelli; F Rumpianesi; C Banzi; L Bovicelli; M P Landini
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.